James A. McCubrey

Affiliations: 
Microbiology and Immunology East Carolina University, Greenville, NC, United States 
Area:
Oncology, Immunology, Genetics
Google:
"James McCubrey"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Akula SM, Candido S, Abrams SL, et al. (2019) Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells. Advances in Biological Regulation. 100672
Akula SM, Abrams SL, Steelman LS, et al. (2019) RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma. Expert Opinion On Therapeutic Targets. 1-15
Akula SM, Candido S, Libra M, et al. (2019) Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells. Advances in Biological Regulation
Hussein HAM, Alfhili MA, Pakala P, et al. (2019) miRNAs and their roles in KSHV pathogenesis. Virus Research
Abrams SL, Follo MY, Steelman LS, et al. (2018) Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells. Advances in Biological Regulation
Abrams SL, Lertpiriyapong K, Yang LV, et al. (2018) Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals. Advances in Biological Regulation
Chappell WH, Candido S, Abrams SL, et al. (2018) Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines. Advances in Biological Regulation
Candido S, Abrams SL, Steelman L, et al. (2018) Metformin influences drug sensitivity in pancreatic cancer cells. Advances in Biological Regulation
Steelman LS, Abrams SL, Ruvolo P, et al. (2017) Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression. Oncotarget. 8: 113013-113033
Abrams SL, Ruvolo PP, Ruvolo VR, et al. (2017) Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells. Oncotarget. 8: 76525-76557
See more...